
This autoimmune disease causes hair loss in both women and men, affecting 160 million people worldwide

The expansion builds on the companies’ strategic alliance previously announced in 2021

The autoimmune disease affects approximately 147 million people globally

£105m will be used to accelerate the diagnosis of rare genetic diseases in newborns

The focus will be on immune modulation within oncology and potentially other disease areas

The findings show opportunities to address organ damage risk for early stage lupus patients

Cold agglutinin disease affects around 12,000 people in the US, Europe and Japan

The study involved the extraction and screening of more than 500 ancient DNA samples

Amgen gains access to the biopharma’s autoimmune disease treatment Tavneos

Auremolimab, which has proven efficacy for vitiligo, is included in the deal

Scanning the papers this last week, we’ve seen a welcome departure from wall-to-wall gloom –and very real signs of ‘Reasons To Be Cheerful’.The economy, we’re told, might not be such...

Merck will gain a pipeline of immune modulators targeting autoimmune diseases